Lipocine's total assets for Q3 2024 were $20.70M, a decrease of -10.13% from the previous quarter. LPCN total liabilities were $1.58M for the fiscal quarter, a -6.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.